Atlas Trials

Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT07008846 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07008846
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Moderate to Severe Rheumatoid Arthritis
Start date
2025-05-10
Primary completion
2026-09-30
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.